The mouse TCRg locus is positively regulated by the transcription factors STAT5 and Runx. While the locus undergoes frequent rearrangements in T lymphocytes, TCRg transcription is repressed in ab T cells. This phenomenon, known as TCRg silencing, depends on pre-TCR-induced thymocyte proliferation. The molecular basis for TCRg silencing, however, is largely unknown. Here, we show that pre-TCR signaling reduces transcription and histone acetylation of the TCRg locus irrespective of V-J rearrangements. We also demonstrate that Runx is recruited to Eg and HsA enhancer elements of the TCRg locus, primarily at the CD4 2 CD8 2 double-negative stage and that Runx binding to these elements decreases at later stages of thymocyte development. Importantly, anti-CD3 antibody treatment decreased IL-7R expression levels, STAT5 phosphorylation and recruitment of STAT5 and Runx to Eg and HsA elements in RAG2-deficient thymocytes, suggesting that pre-TCR signaling triggers reduced binding of STAT5 and Runx to the enhancer elements. Furthermore, we observed that misexpression of STAT5 or Runx in the CD4 1 CD8 1 double-positive cell line DPK induces TCRg gene transcription. Finally, we showed that TCRg transcription is induced in ab T cells from Runx3 transgenic mice, suggesting that Runx3 counteracts TCRg silencing in ab T cells in vivo. Our results suggest that pre-TCR signaling indirectly inactivates TCRg enhancers by reducing recruitment of STAT5 and Runx and imply that this effect is an important step for TCRg silencing in ab T cells.
Introduction
Development of ab and cd T cells requires functional rearrangement of TCR genes. During thymocyte development, TCRb, TCRc and TCRd genes are rearranged at the CD4 À
CD8
À double-negative (DN) stage, especially from DN2 (CD25
+ ) to DN3 (CD25 + CD44 À ) stages. When functional rearrangements take place at the TCRc and TCRd loci, T precursors develop into cd T cells. Nascent TCRb chains pair with pre-TCR a-chains to form pre-TCR, which induces proliferation and subsequent differentiation into CD4 +
+ double-positive (DP) stage cells. In DP cells, the TCRd locus is deleted by recombination of the TCRa locus and productively rearranged TCRa chains dimerize with the TCRb chains to form abTCR. Although the TCRc locus is frequently rearranged, its transcription is repressed in ab T cells, a phenomenon known as TCRc silencing (1) . Extinction of TCRc transcription is important for normal ab T-cell development because the TCRc chain can pair with the TCRa chain to form 'acTCR', which blocks differentiation into mature ab T cells (2) .
The TCRc locus is controlled by several transcription factors. The mouse TCRc locus consists of four related clusters, c1, c2, c3 and c4, each containing Vc, Jc and Cc gene segments as well as a 3# enhancer (Ec) element (3) (4) (5) . The TCR c1 cluster contains an additional enhancer element, HsA, between the Vc5 and Vc2 gene segments (6) . Studies with Ec1-or/and HsA-deleted mice suggest that Ec1 and HsA elements are mostly redundant and are primarily responsible for transcription of the TCR c1 cluster (7) . Runx and c-Myb-related transcription factors reportedly interact with and control Ec elements (8, 9) . In addition, STAT5 activated by IL-7R binds to germline promoters of the Jc gene segments and controls local chromatin accessibility by recruiting transcriptional coactivators and inducing histone acetylation and germline transcription (10) (11) (12) (13) (14) . Furthermore, STAT5 is recruited to consensus motifs in the Ec elements and augments their transcriptional enhancer activity (12, 15) . Finally, we recently reported that STAT5 also binds to the HsA element and induces histone acetylation (16) .
The mechanism of TCRc silencing remains a matter of debate. Putative cis-acting silencer elements were proposed to exist in the 3# regions of mouse and human Cc gene segments (17) (18) (19) . Transgenic (Tg) mice with rearranged TCR c1 transgenes showed TCRc silencing when transgenes contained the 3# region of the Ec1 element (17, 19) . On the other hand, others report that the TCRc locus is silenced in ab T cells in TCRc Tg mice lacking the silencer region (20) . There is also an interesting report that TCRc genes are highly transcribed in DP thymocytes from mice lacking a pre-TCR signal, suggesting that TCRc silencing requires pre-TCR signal-induced thymocyte proliferation (1) . However, the mechanism underlying TCRc silencing induced by a pre-TCR signal is largely unknown.
To define the molecular mechanisms promoting TCRc silencing by pre-TCR, we analyzed recruitment of STAT5 and Runx to enhancer elements of the TCRc locus in ab T cells. The pre-TCR signal reduced transcription of TCRc genes and histone acetylation of the Ec1 and HsA elements and prevented STAT5 and Runx from binding to these enhancers. Furthermore, over-expression of STAT5 or Runx induced TCRc transcription in ab T cells in vitro and in vivo. This study suggests that pre-TCR signaling indirectly inactivates TCRc enhancers by reducing recruitment of STAT5 and Runx and defines an important step in TCRc silencing. À/À thymocytes 6 days after antibody injection, as described in (B).
Methods

Mice
C57BL/6 mice were purchased from Japan SLC (Hamamatsu, Japan). Rag2 À/À mice (21) on a C57BL/6 background were obtained from Dr M. Ito at Central Laboratories for Experimental Animals, Kawasaki, Japan (and were originally a kind gift of Dr F. W. Alt at Harvard Medical School). IL-7Ra À/À H-2K-Bcl-2 Tg mice (a kind gift of Dr J. Domen at the Medical College of Wisconsin) have been described (22) . The Tg mouse line expressing the mouse Runx3 transgene under control of the lck promoter was previously described (23) . All mice were maintained under specific pathogen-free conditions at the Experimental Research Center for Infectious Diseases at the Institute for Virus Research, Kyoto University, and all mouse protocols were approved by Kyoto University.
Cell culture
A mouse pre-T-cell line, Scid.adh-TAC:CD3e (24) (a kind gift of Dr D. L. Wiest at Fox Chase Cancer Center), was cultured as described (15) . A mouse CD4
+ CD8 + DP cell line DPK (25) (a kind gift of Dr J. Kaye at The Scripps Research Institute) was maintained in RPMI-1640 medium containing 10% fetal bovine serum, 50 lM 2-mercaptoethanol, 10 mM HEPES (pH 7.4), 1 mM sodium pyruvate and 1 3 non-essential amino acids. IL-7 was prepared as high-titer conditioned media of J558-mIL-7 cells (a kind gift of Dr H. Karasuyama, Tokyo Medical and Dental University). Wild-type (WT)-STAT5a, constitutively active (CA)-STAT5a, Runx1 and Runx3 cDNAs were subcloned into pMX-IRES-puro (pMX-IP, a kind gift of Dr T. Kitamura of the University of Tokyo) as described (26) . Plat-A packaging cells (27) were transfected with pMX-IP, pMX-WT-STAT5a-IP, pMX-CASTAT5a-IP, pMX-Runx1-IP or pMX-Runx3-IP vectors, and retrovirus-containing supernatants were used to infect DPK cells.
Cell isolation, antibodies and flow cytometry
CD4
À CD8 À CD3 À triple-negative (TN), DP, CD4 single-positive (SP) and CD8 SP thymocytes were isolated from WT mice using magnetic microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and a cell sorter (FACSAria, BD Biosciences, San Fig. 2 . The pre-TCR signal decreases histone acetylation at the TCRc locus. For ChIP analysis, soluble chromatin was prepared from TN, DP, CD4 SP and CD8 SP thymocytes from adult WT mice (A) or from Rag2
À/À thymocytes 6 days after anti-CD3 antibody injection (B) and immunoprecipitated with anti-acetylated histone H3 antibody or control IgG. The amount of ChIP DNA as assessed by real-time PCR was normalized with that of input DNA. Jj1 serves as a negative control locus. Values are the mean 6 SE of triplicate data points. The data represent one of three independent experiments with similar results. Student's t-test for unpaired data was used to compare values between the two groups (*P < 0.05, **P < 0.01).
Jose, CA, USA). Briefly, to enrich for TN and SP subpopulations, CD4
+ , CD8 + and TER-119 + cells were first depleted from total thymocytes with CD4, CD8 and TER-119 magnetic microbeads, respectively. The cells were then stained with FITC-anti-CD8a (53-6.7), PE-anti-CD4 (GK1.5) and allophycocyanin (APC)-anti-CD3 antibodies (145-2C11) (eBioscience, San Diego, CA, USA), and TN and SP subpopulations were sorted. CD4 SP and CD8 SP subpopulations were isolated with a CD3 high gate. Lymph node cells were stained with FITCanti-CD8a, PE-anti-CD4, APC-anti-TCRb antibodies (H57-597) (eBioscience) and CD4 and CD8 T cells were sorted. Lymph node cd T cells were isolated from IL-7Ra flox/flox 3 CD4-Cre Tg mice (S. Tani-ichi et al., unpublished data). Cells were stained with FITC-anti-abTCR, PE-anti-cdTCR (GL-3) (Pharmingen and BD Biosciences) and APC-anti-CD3 antibodies and sorted. The purity of each population was >95%. TN thymocytes were isolated from WT and IL-7Ra À/À H-2K-Bcl-2 Tg mice as described (12) . Anti-CD3e antibody (145-2C11, 300 lg) was injected intra-peritoneally into 5-to 7-week-old Rag2 À/À mice. Thymocytes were isolated at 4, 6 or 7 days after injection. For analysis, thymocytes were stained with the following antibodies: FITC-anti-CD8a, PE-anti-CD4, APC-anti-CD3, biotin-anti-IL-7Ra (A7R34), rat IgG2a isotype control and streptavidin-PE (eBioscience). Cells were analyzed by a FACSCalibur (BD Biosciences) with CELLQuest Pro software (BD Biosciences). Debris and dead cells were excluded from the analysis by forward and side scatter and propidium iodide gatings.
Real-time reverse transcriptase-PCR
Total RNA was extracted with TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) and treated by RQ1 RNase-Free DNase (Promega, Madison, WI, USA) to remove genomic DNA. RNA was then reverse-transcribed, using ReverTra Ace (TOYOBO, Osaka, Japan) with random primers. cDNA was amplified as described (15). For quantification, cDNA of TN thymocytes from adult WT mice and genomic DNA from Ba/F3 cells were used as amplification standards for rearranged and germline transcripts, respectively. Primer sequences for V-J rearranged transcripts were as follows: Vc5-Jc1/F, 5#-ACAACTGTGGTGGATTCCAGA-3#, and Jc1-1 (12) for Vc5-Jc1; and Vc2-Jc1/F, 5#-GTAACCATA CACTGGTACCG-3#, and Jc1 (28) for Vc2-Jc1. Primer sequences for germline transcripts were as follows: Vc5-gF, 5#-TAT-GAAGGCCCGGACAAGAGG-3#, and Vc5-gR, 5#-GAGGGATAC-TGGATTGTCAC-3#; Vc2-gF, 5#-GTAACCATACACTGGTACCG-3#, and V2-3#b (29); Vc4-gF, 5#-ACATGGCAGAGTGATTTGTC-3#, and V4-3#a (29) ; and Vc3 (28) and V3-3#a (29) .
Electrophoretic mobility shift assay
Electrophoretic mobility shift assay (EMSA) was performed as described (26) . For supershift assays, 1 lg of normal rabbit IgG (Upstate Biotechnology, Millipore, Billerica, MA, USA) or anti-pan-Runx antibody (30) was added to the reaction. The sequence of the oligonucleotide probe was (Runx-binding motif underlined): HsA-Runx, 5#-CAAGGGAAACCAGAAAGG-GAGT-3#. For competition assays, a 10-fold excess of cold probe harboring the Runx consensus motif in the TCRb enhancer (5#-TCTAACAGGATGTGGTTTGACATT-3#) was added. Binding reactions were resolved by 5% PAGE. DNA/ protein complexes were transferred to Zeta-Probe Membranes (Bio-Rad Laboratories, Hercules, CA, USA) and visualized using a Chemiluminescent Nucleic Acid Detection Module (Thermo Fisher Scientific, Waltham, MA, USA), and luminescence intensity was detected using a lumino-image analyzer LAS-4000 mini (FUJIFILM, Tokyo, Japan).
Chromatin immunoprecipitation assay
A chromatin immunoprecipitation (ChIP) assay was performed as described (12, 14, 15) . Briefly, soluble chromatin consisting 200-to 1000-bp fragments was immunoprecipitated with antiacetylated histone H3 antibody (Upstate Biotechnology), rabbit anti-pan-Runx antibody (30) , mixture of anti-STAT5A antibody and anti-STAT5B antibody (R&D Systems, Minneapolis, MN, USA) or an equal amount of normal rabbit IgG (Upstate Biotechnology) overnight at 4°C. Purified ChIP and input DNAs were measured by PCR and real-time quantitative PCR. Serial dilution of sonicated genomic DNA from Rag2 À/À thymocytes served as a calibration control. ChIP DNA levels were normalized to those of input DNA. In each experiment, samples were analyzed in duplicate or triplicate. PCR primer sequences were as follows: Vc5-5#ChIP and Vc5-3#ChIP; Vc2-5#ChIP and Vc2-3#ChIP; HsA-5#ChIP and HsA-3#ChIP; Cc1-5#ChIP and Cc1-3#ChIP (16); Ec1/F and Ec1/R; Ec4/F and Ec4/R (15); and Cc4/F, 5#-GACAAACGCACTGACTCAGACT-3# and Cc4/R, 5#-GGATTCCAGAATCTTTTCACCATC-3#.
Western blotting
Immunoprecipitation was carried out as described (26) . Immunoprecipitates (equivalent to 1 3 10 7 cells) were subjected to 8% SDS-PAGE, transferred to polyvinylidene difluoride membranes (Immobilon-P; Millipore), and blotted with anti-phospho-STAT5 antibody (Upstate Biotechnology). Whole cell lysates (derived from 3 3 10 6 cells) were subjected to 8% SDS-PAGE and immunoblotted with a mixture of anti-STAT5a and anti-STAT5b antibodies or anti-pan-Runx antibody. Chemiluminescence was developed using the ECL detection system (GE Healthcare, Buckinghamshire, UK) and detected using the lumino-image analyzer.
Results
Pre-TCR signaling inhibits transcription of the TCRc locus irrespective of Vc-Jc rearrangement
The TCRc locus is rearranged in the majority of DP thymocytes (31, 32) , while its transcription is strongly suppressed (1, 17) . To investigate whether germline transcription of the TCRc locus is also repressed in ab T lineage cells, we compared Vc-Jc rearranged and germline transcripts over the course of thymocyte development. To do so, we isolated TN, DP and SP subpopulations from WT thymus and analyzed rearranged and germline transcripts by real-time reverse transcriptase (RT)-PCR. While levels of rearranged Vc5-Jc1 and Vc2-Jc1 transcripts were high in TN thymocytes, they were sharply decreased in DP and SP subpopulations (Fig. 1A) . Similarly, levels of Vc5 and Vc2 germline transcripts were also markedly decreased after the DP stage (Fig. 1B) . These results strongly À/À thymocytes 6 days after anti-CD3 antibody injection and immunoprecipitated with anti-STAT5 antibody or control IgG. Binding was revealed by agarose gel electrophoresis (left) and real-time PCR (right). Jj1 is a negative control locus. Quantification was performed as described in Fig. 2 . Values are the mean 6 SE of duplicate data points. Student's t-test for unpaired data was used to compare values between groups (*P < 0.05, **P < 0.01). The data represent one of two independent experiments with similar results.
TCRc silencing via enhancer inhibition 557 suggest that transcriptional silencing begins during the transition from the DN to DP stage when b-selection occurs in ab T cells.
Studies of TCRb À/À TCRd À/À mice indicate that the pre-TCR signal is important for TCRc silencing (1). However, the TCRc chain can dimerize with the pre-TCR a-chain to form a novel TCR (19) , and the frequency of non-productive Vc-Jc rearrangements is higher in ab T cells than in cd T cells (33) . To exclude the possibility that Vc-Jc rearrangements affect TCRc silencing in ab T cells, we injected Rag2
, rather than TCRb À/À TCRd À/À mice, with anti-CD3 antibody, which mimics the pre-TCR signal (34, 35) . Six days later, a significant fraction of thymocytes differentiated to the DP stage, and total thymocyte number was greatly increased (Fig. 1C) . Simultaneously, germline transcript levels were clearly reduced at Vc5 and Vc2 gene segments (Fig. 1D) . These results indicate that transcriptional silencing of the TCRc locus is induced by pre-TCR signaling, irrespective of Vc-Jc rearrangement.
The pre-TCR signal reduces histone acetylation of the TCRc locus Because histone acetylation is generally associated with enhanced transcription, we measured histone H3 acetylation of the TCRc locus during T-cell development. To do so, we isolated thymocyte subpopulations from WT mice and carried out ChIP analysis with anti-acetylated histone H3 antibody. In agreement with data shown in Fig. 1(A and B) , levels of histone H3 acetylation were severely reduced at the Vc2 gene segment in DP and SP thymocytes ( Fig. 2A) . In addition, histone acetylation was slightly decreased at the Vc5 gene segment. Interestingly, levels of histone H3 acetylation were also reduced at the HsA and Ec1 elements after the DP stage. These results suggest that histone acetylation is correlated with transcription in the TCRc locus and then both histone acetylation and transcription decrease at DP and SP stages.
Next, we asked whether pre-TCR signaling decreases histone acetylation of the TCRc locus by analyzing histone H3 acetylation in Rag2 À/À thymocytes treated with anti-CD3 antibody. Histone H3 acetylation levels were significantly reduced at Vc5 and Vc2 gene segments after antibody treatment (Fig. 2B) . As seen in WT thymocytes ( Fig. 2A) , histone H3 acetylation was also diminished at the HsA and Ec1 elements. These results indicate that pre-TCR signaling reduces histone acetylation of the TCRc locus.
Runx is recruited to the HsA element
Because Runx transcription factors control Ec elements in cooperation with STAT5 (15), we asked whether Runx binds to the HsA element. First, we examined the sequence of the HsA Fig. 5 . Runx is recruited to Ec and HsA elements primarily at the DN stage. (A) Thymocyte subpopulations were subjected to a ChIP assay with anti-Runx antibody as described in Fig. 3 
(C). (B and C) Lymph node CD4 and CD8 ab T cells and cd T cells were subjected to ChIP analysis with anti-Runx antibody (B) or anti-acetylated histone H3 antibody (C), as described in Figs. 2 and 3(C)
. Eb and Jj1 serve as a positive control locus and a negative control locus, respectively. Values are the mean 6 SE of duplicate data points. Student's t-test for unpaired data was used to compare values between groups (*P < 0.05, **P < 0.01). The data represent one of three independent experiments with similar results. 
(C) Rag2
À/À thymocytes were isolated 6 days after anti-CD3 antibody injection and subjected to immunoblot analysis with anti-pan-Runx antibody.
TCRc silencing via enhancer inhibition 559 element using the rVISTA 2.0 program (36) and identified an atypical Runx-binding motif conserved between human and mouse HsA elements (Fig. 3A) . To determine whether Runx binds to the motif, we carried out EMSA analysis. Nuclear extracts were isolated from HEK293T cells transfected with Runx3 vector to EMSA. We detected Runx binding to the HsA element and that binding was competed with a cold probe for the Runx motif and supershifted with anti-Runx antibody (Fig. 3B ). These results demonstrate that Runx binds to a consensus motif in the HsA element in vitro.
Next, we employed ChIP to determine whether Runx binds to the HsA element in endogenous chromatin. Soluble chromatin was isolated from a mouse pre-T cell line, Scid.adh or from control Rag2 À/À thymocytes and immunoprecipitated with an anti-pan-Runx antibody or control IgG. In case of Scid.adh cells, Ec4 and Cc4 genes were analyzed rather than Ec1 and Cc1 because these cells lack a large part of the TCR c1 cluster (data not shown). We observed weak but evident recruitment of a Runx factor to the HsA element as well as to the Ec4 element in Scid.adh cells (Fig. 3C, left) . Because Scid.adh cells express Runx1 but not Runx3 (data not shown), these results suggest that Runx1 is recruited to the HsA element. Runx was also specifically recruited to HsA and Ec1 elements in Rag2 À/À thymocytes (Fig. 3C,   right ). These and other results indicate that Runx and STAT5 are recruited to HsA and Ec elements.
The pre-TCR signal inhibits STAT5 recruitment to Ec and HsA elements
Next, to test whether the pre-TCR signal inhibits STAT5 binding to Ec and HsA elements, we analyzed Rag2 À/À mice injected with anti-CD3 antibody using a ChIP assay with anti-STAT5 antibody. Rag2 À/À thymocytes showed diminished IL-7Ra expression after antibody injection (Fig. 4A ), in agreement with previous reports that IL-7Ra is down-regulated in DP thymocytes (37) (38) (39) . Consequently, levels of phosphorylated STAT5 were also reduced (Fig. 4B) . As expected, binding of STAT5 to Ec1 and HsA elements was abolished after anti-CD3 antibody injection (Fig. 4C) . These results suggest that pre-TCR signaling diminishes IL-7Ra expression and STAT5 phosphorylation, inhibiting STAT5 recruitment to the Ec and HsA elements.
Runx is recruited to Ec and HsA elements mainly at the DN stage
We next asked at what stages of thymocyte development Runx is recruited to Ec and HsA elements. While Runx1 expression is high at the DN stage and low at DP and SP stages, Runx3 is mainly expressed at CD8 SP stage (40) . We isolated thymocyte subpopulations from WT mice and carried out ChIP analysis using an anti-pan-Runx antibody. The Eb element showed significant levels of Runx binding as reported previously (41) (Fig. 5A) . Levels of Runx binding to the HsA and Ec1 elements were highest in TN thymocytes but reduced at DP and SP thymocytes. These results suggest that Runx is recruited to Ec and HsA elements mainly at the DN stage and that their binding is decreased during b-selection.
Because transcription of the TCRc locus is repressed in peripheral ab T cells (1, 17), we asked whether Runx recruitment to Ec and HsA elements is lost in peripheral T cells. Lymph node cd T cells showed higher levels of Runx binding to the Ec1 and HsA elements than did CD4 and CD8 ab T cells (Fig. 5B) . Unexpectedly, ab T cells also showed significant levels of Runx binding to the HsA element. We next analyzed histone acetylation in peripheral T cells. In agreement with Runx binding, levels of histone H3 acetylation tended to be higher in cd T cells than in ab T cells, although CD4 T cells showed significant histone H3 acetylation at the HsA element (Fig. 5C ). The levels of IgG control were unexpectedly high at HsA element in cd T cells for unknown reason. These results suggest that Runx binding to Ec and HsA elements is partly correlated with transcription at the TCRc locus in peripheral T cells.
The pre-TCR signal inhibits recruitment of Runx to Ec and HsA elements
Next, to test whether pre-TCR signaling inhibits Runx binding to Ec and HsA elements, we employed ChIP with the pan-Runx antibody to analyze Rag2 À/À mice injected with anti-CD3 antibody. Approximately 10 and 80% of Rag2 À/À thymocytes differentiated to the DP stage at 4 and 6 days, respectively (Fig. 6A) . Runx binding to HsA and Ec1 elements gradually decreased after anti-CD3 antibody treatment (Fig. 6B) , possibly because Runx mRNA and protein levels are reportedly lower at DP than at DN stages (40, 42) . Indeed, Rag2
À/À thymocytes showed reduced levels of Runx protein after anti-CD3 antibody injection (Fig. 6C) . These results suggest that the pre-TCR signal triggers reduction of Runx protein levels and consequently inhibits recruitment of Runx to Ec and HsA elements at the DP stage.
STAT5 and Runx induce transcription of TCRc genes in a DP cell line
Inhibition of STAT5 and Runx recruitment by the pre-TCR signal could be either the cause or the result of the closedchromatin status at the TCRc locus during commitment into ab T cells. To examine whether STAT5 and Runx can open chromatin at the TCRc locus, we employed the CD4 + CD8 + DP T cell line DPK (25) . DPK cells differentiate into CD4 SP cells upon TCR stimulation (25) and express low levels of IL-7Ra (Fig. 7A) (Fig. 7B ). In addition, Runx3 induced Vc3 germline transcripts. Notably, IL-7 stimulation induced all Vc and Jc1 germline transcripts in Runxtransduced DPK cells, probably because activated STAT5 elevated the activity of Ec1 element. Furthermore, overexpression of Runx induced Vc-Jc1 transcripts, and IL-7 treatment increased their levels (Fig. 7C ).
We next asked whether STAT5 opens chromatin of the TCRc locus in DPK cells. To do so, we introduced control, WT-STAT5a or CA-STAT5a vector into DPK cells. Seven days after puromycin selection, all DPK cells retained the CD4 +
CD8
+ phenotype (Fig. 7D) . Similar to Runx, introduction of CA-STAT5a induced expression of Vc2 germline transcripts (Fig. 7E) . In addition, introduction of WT-or CA-STAT5a induced all Vc and Jc1 germline transcripts after IL-7 stimulation. This is probably because CA-STAT5a has to be first phosphorylated to display its activity. Furthermore, over-expression of STAT5a induced Vc-Jc transcripts upon IL-7 stimulation (Fig. 7F) . These Vc-Jc transcripts were likely derived from rearranged alleles because a small fraction of DPK cells have Vc2-Jc1 and Vc5-Jc1 rearranged genes (data not shown). These results suggest that Runx and STAT5 induce transcription of the TCRc locus in DP cells.
A Runx3 transgene induces transcription of TCRc genes in ab T cells
Finally, we asked whether Runx over-expression induces transcription of the TCRc locus in ab T cells in vivo. Thymocytes and lymph node T cells were isolated from Runx3 Tg mice (23) , and TCRc transcripts were analyzed by real-time RT-PCR. Compared with non-Tg littermates, Runx3 Tg mice showed increased levels of Vc-Jc transcripts in all thymocyte subpopulations except for Vc2-Jc1 transcripts in CD4 SP cells (Fig. 8A) , while levels of Vc-Jc rearrangements were not elevated (data not shown). In the periphery of Runx3 Tg mice, both Vc5-Jc1 and Vc2-Jc1 transcripts were increased, particularly in CD8 T cells (Fig. 8B) . These results suggest that Runx3 can counteract TCRc silencing in ab T cells in vivo.
Discussion
In this study, we show that pre-TCR signaling inhibits transcription and histone acetylation of the TCRc locus irrespective of Vc-Jc rearrangement (Figs. 1 and 2) . We also observe that pre-TCR signaling inhibits recruitment of STAT5 and Runx to Ec and HsA elements (Figs. 3-6 ). Finally, we show that STAT5 and Runx have the potential to open the TCRc locus in a DP T cell line and that a Runx3 transgene inhibits TCRc silencing in ab T cells in vivo (Figs. 7 and 8) .
The molecular mechanism underlying TCRc silencing is still unknown. Studies of TCRc Tg mice suggest that silencer elements are present in 3# region of Cc genes (17, 19) . However, there is a conflicting report that the TCRc locus is silenced in ab T cells in TCRc Tg mice lacking the silencer region (20) . Furthermore, there is no DNA sequence conserved between mice and humans in putative silencer regions (data not shown). Therefore, differences in transgene copy number and/or integration site may alter transgene expression and thereby block TCRc silencing. Future gene targeting analysis of the silencer region should resolve issue. In this study, we show that pre-TCR signaling promotes TCRc silencing by inhibiting recruitment of STAT5 and Runx to the Ec and HsA elements. Although our study does not exclude the silencer model, it strongly suggests that the putative silencer is not the only factor regulating TCRc silencing.
It is still unknown whether pre-TCR signal directly controls TCRc silencing. Pre-TCR signal triggers thymocyte development from the DN stage to the DP stage, which induces reduction of Runx and phosphorylated STAT5 proteins. This is probably the major cause of decreased recruitment of STAT5 and Runx to the Ec and HsA elements in DP thymocytes. It will be necessary to carefully examine whether pre-TCR signal directly regulates modifications or activities of STAT5 and Runx proteins especially at early phase of pre-TCR stimulation such as at 24 h. In addition, DN fraction might contain ab-and cd-committed progenitors with silenced and activated TCRc locus, respectively, and pre-TCR signal might increase only ab lineage cells. In this case, the transcription and histone acetylation will decrease without real silencing of the TCRc locus. This possibility should be carefully examined in future.
SP thymocytes maintain TCRc silencing by as yet undetermined mechanisms. Although IL-7R is re-expressed and STAT5 is phosphorylated in CD4 SP and CD8 SP thymocytes, the levels of STAT5 phosphorylation are much lower than in DN thymocytes (38) . In addition, although DP and SP thymocytes show significant levels of Runx recruitment to the HsA element (Fig. 5A ) and histone H3 acetylation at both Ec and HsA elements, Runx recruitment to Ec1 element was at lower levels compared with DN thymocytes (Fig. 2A) . Furthermore, although CD8 SP thymocytes express higher levels of Runx3
TCRc silencing via enhancer inhibition 561 protein than other thymocytes (40) , Runx recruitment to the Ec1 element remained at low levels in CD8 SP thymocytes (Fig. 5A) . Because both Runx and STAT5 are required for maximum activity of the Ec elements (15) , dissociation of Runx from those elements would greatly reduce enhancer activity, irrespective of STAT5 recruitment. Although SP thymocytes showed significant levels of histone H3 acetylation at Ec elements ( Fig. 2A) , modification or changes in subnuclear localization of TCRc chromatin could contribute to the inactive status of Ec elements in SP thymocytes.
Peripheral ab T cells may exhibit partially active TCRc chromatin. CD4 and CD8 T cells showed detectable levels of Runx binding to the HsA element and histone H3 acetylation at the Ec and HsA elements (Fig. 5B and C) . TCRc transcripts are reportedly induced in CD4 T cells after IL-7 stimulation (43), likely due to the open chromatin status at the TCRc locus in ab T cells. Because peripheral lymphoid organs express IL-7 at lower levels than thymus (44) , STAT5 activation may be lower in peripheral ab T cells, accounting for repression of the TCRc locus observed in those cells.
In conclusion, our results demonstrate that pre-TCR signaling inactivates TCRc enhancers by inhibiting recruitment of STAT5 and Runx and suggest that this activity is an important step for TCRc silencing in ab T cells. Our study provides a molecular explanation for how cd T cells maintain transcription of TCRc genes and sheds light on differences between ab and cd T cells.
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